Welcome to our dedicated page for Dakshidin news (Ticker: DKSC), a resource for investors and traders seeking the latest updates and insights on Dakshidin stock.
Dakshidin Corporation (DKSC) delivers innovative health and wellness solutions through strategic acquisitions and leadership expertise. This news hub provides investors and industry observers with official updates on corporate developments shaping the company's market position.
Access timely announcements including intellectual property acquisitions, executive appointments, and product portfolio expansions. Our curated feed ensures transparent tracking of material events like the recent Stenergy LLC IP integration and Samuel J. Butero's operational leadership contributions.
Discover updates across key business areas: strategic partnerships, research advancements, and regulatory milestones. Bookmark this page for direct access to verified corporate communications that impact DKSC's growth trajectory in the wellness sector.
SAN FRANCISCO, CA / ACCESSWIRE / September 14, 2021 / Whitechapel, a subsidiary of Dakshidin Corporation (OTC PINK:DKSC), is set to launch a series of webinars focused on health and wellness. Topics will include superfoods, specifically the Queen Garnet Plum, pain relief from Sea Moss, and sustainable health practices. The webinars will feature experts from various fields and will be available for later viewing on the Whitechapel website. The first webinar is scheduled to air this fall, aiming to enhance public knowledge and promote an organic lifestyle.
Dakshidin Corporation (OTC: DKSC) announced the relaunch of its corporate website and Laughingfrogs.com, featuring proprietary CBD products and nutraceuticals, including Queen Garnet Plum and BioSea Health line of SeaMoss products. CEO Chris Haigh expressed excitement about collaborating with Cicero Media Group for optimized online marketing and upcoming webinars on nutraceuticals and wellness. These initiatives aim to strengthen the company’s position in the organic health sector.
Whitechapel Holdings, a subsidiary of Dakshidin Corporation (OTC PINK:DKSC), has entered into an exclusive distribution agreement with BioSea Health for all-natural seaweed-based products. Dr. Hugh Butler emphasizes the health benefits of seaweed, including anti-inflammatory properties and immune support. The BioSea Health product line features Pacific Seamoss, noted for its positive effects in a trial involving over 140 participants experiencing period pain and joint discomfort. CEO Christopher Haigh expresses optimism for a long-term partnership with BioSea Health.
Dakshidin Corp (DKSC) announced a strategic partnership with GenBio Inc, focusing on developing anti-inflammatory drugs derived from natural extracts. CEO Chris Haigh noted that the collaboration, which aligns with their rebranding to Whitechapel Holdings, aims to leverage unique products addressing health issues post-pandemic. GenBio's research has identified promising extracts and mechanisms of action, potentially leading to a groundbreaking Investigational New Drug program in the U.S. This initiative targets the expanding health and wellness market, expected to impact sales significantly in the coming quarters.
Dakshidin Corporation (DKSC) has entered a business development and data management agreement with Cicero Media Group, enhancing its marketing strategy and outreach. Cicero will provide targeted data to Whitechapel Holdings, a subsidiary of Dakshidin, aiding in website redesign and customer engagement. This collaboration aims to broaden customer reach and promote new product lines in nutraceuticals, pet supplements, and CBD.
CEO Chris Haigh expresses optimism regarding this partnership, emphasizing Cicero's expertise in social media.
